Source: LOHAS Weekly Newsletter
Published: Wednesday, November 27, 2002

As part of an ongoing investigation, San Diego-based supplements manufacturer Metabolife International Inc. turned over on Nov. 19 an additional 1,400 customer complaints to the Food and Drug Administration (FDA), which document the side effects of its ephedra supplement, according to ABC News online. The newly released reports include 14 that regard serious side effects; Metabolife says it did not release the additional reports earlier due to a computer glitch.

Separately, the company was ordered by a federal jury in Birmingham, Ala., to pay $4.1 million to four people who claim they suffered strokes or heart attacks due to the company's ephedra diet supplement, Metabolife 356, according to a Nov. 20 article at TheSanDiegoChannel.com.